Genexine, Inc. (095700.KQ)

KRW 5590.0

(-3.79%)

Inventory Summary of Genexine, Inc.

Genexine, Inc.'s latest annual inventory in 2023 was 3.8 Billion KRW , down -68.35% from previous year.
Genexine, Inc.'s latest quarterly inventory in 2024 Q1 was 3.79 Billion KRW , down -0.32% from previous quarter.
Genexine, Inc. reported annual inventory of 12.02 Billion KRW in 2022, up 67.73% from previous year.
Genexine, Inc. reported annual inventory of 7.17 Billion KRW in 2021, up 577.5% from previous year.
Genexine, Inc. reported quarterly inventory of 3.36 Billion KRW for 2024 Q2, down -11.22% from previous quarter.
Genexine, Inc. reported quarterly inventory of 9.55 Billion KRW for 2023 Q3, down -18.13% from previous quarter.

Annual Inventory Chart of Genexine, Inc. (2023 - 2012)

Historical Annual Inventory of Genexine, Inc. (2023 - 2012)

Year	Inventory	Inventory Growth
2023	3.8 Billion KRW	-68.35%
2022	12.02 Billion KRW	67.73%
2021	7.17 Billion KRW	577.5%
2020	-1.5 Billion KRW	96.38%
2019	-41.46 Billion KRW	0.0%
2018	- KRW	0.0%
2017	- KRW	-100.0%
2016	128.57 Million KRW	-32.93%
2015	191.7 Million KRW	0.0%
2012	- KRW	0.0%

Year	Inventory	Inventory Growth
2024 Q1	3.79 Billion KRW	-0.32%
2024 Q2	3.36 Billion KRW	-11.22%
2023 Q3	9.55 Billion KRW	-18.13%
2023 Q2	11.67 Billion KRW	-3.47%
2023 Q1	12.09 Billion KRW	0.54%
2023 FY	3.8 Billion KRW	-68.35%
2023 Q4	3.8 Billion KRW	-60.16%
2022 Q2	- KRW	-100.0%
2022 Q1	1.00 KRW	-100.0%
2022 FY	12.02 Billion KRW	67.73%
2022 Q4	12.02 Billion KRW	0.0%
2022 Q3	- KRW	0.0%
2021 Q3	2.77 Billion KRW	174.76%
2021 Q4	7.17 Billion KRW	158.64%
2021 FY	7.17 Billion KRW	577.5%
2021 Q1	-3.7 Billion KRW	-146.64%
2021 Q2	-3.7 Billion KRW	-0.13%
2020 Q2	-9.99 Billion KRW	75.29%
2020 FY	-1.5 Billion KRW	96.38%
2020 Q4	-1.5 Billion KRW	0.0%
2020 Q3	- KRW	100.0%
2020 Q1	-40.47 Billion KRW	2.39%
2019 Q4	-41.46 Billion KRW	0.0%
2019 FY	-41.46 Billion KRW	0.0%
2018 FY	- KRW	0.0%
2017 FY	- KRW	-100.0%
2016 FY	128.57 Million KRW	-32.93%
2015 FY	191.7 Million KRW	0.0%
2013 Q3	174.5 Million KRW	0.0%
2012 FY	- KRW	0.0%

Peer Inventory Comparison of Genexine, Inc.

Name	Inventory	Inventory Difference
HLB Co., Ltd.	11.42 Billion KRW	66.669%
iNtRON Biotechnology, Inc.	1.01 Billion KRW	-276.513%
BINEX Co., Ltd.	28.26 Billion KRW	86.53%
Bioneer Corporation	41.35 Billion KRW	90.794%
Anterogen.Co.,Ltd.	1.91 Billion KRW	-99.263%
MEDIPOST Co., Ltd.	14.51 Billion KRW	73.776%
CrystalGenomics, Inc.	1.55 Billion USD	-144.852%
Helixmith Co., Ltd	914.11 Million KRW	-316.462%
Chabiotech Co.,Ltd.	34.11 Billion KRW	88.841%
Medy-Tox Inc.	59.61 Billion KRW	93.614%
Peptron, Inc.	172.18 Million KRW	-2110.925%
Amicogen, Inc.	46.83 Billion KRW	91.872%
HLB Therapeutics Co.,Ltd.	5.33 Billion KRW	28.653%
LegoChem Biosciences, Inc.	196.83 Million KRW	-1834.08%
ALTEOGEN Inc.	1.06 Billion KRW	-256.335%
PharmaResearch Co., Ltd.	50.23 Billion KRW	92.421%
SillaJen, Inc.	1.21 Billion KRW	-213.942%
JETEMA, Co., Ltd.	12.74 Billion KRW	70.12%
OliX Pharmaceuticals,Inc	468.4 Million KRW	-712.737%
Genomictree Inc.	496.53 Million KRW	-666.706%
MedPacto, Inc.	620.00 KRW	-614021512.903%
D&D Pharmatech	3.45 Billion KRW	-10.339%
EASY BIO,Inc.	25.93 Billion KRW	85.323%
GI Innovation, Inc.	- KRW	-Infinity%